Louis-Martin Boucher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Louis-Martin Boucher has a total of 216 co-authors. Here are the top co-authors by number of shared publications:
- David Valenti
Department of Diagnostic Radiology, McGill University, 845 Rue Sherbrooke O, Montréal, QC H3A 0G4, Canada
32 shared publications Jamil Asselah
29 shared publications- Adeline Cuggia
The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
28 shared publications - Alain Pacis
Canadian Centre for Computational Genomics, McGill University
28 shared publications - Amy Zhang
Ontario Institute for Cancer Research, Toronto, ON, Canada
28 shared publications - Ayelet Borgida
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
28 shared publications
Latest Publications
- 30 June 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (9) , 108918
Launching an Image-Guided Percutaneous Osteosynthesis Program: A PRISM–RE-AIM Implementation Framework
- 30 June 2026
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (9) , 108918
Launching an Image-Guided Percutaneous Osteosynthesis Program: A PRISM–RE-AIM Implementation Framework
- Open Access
- 8 January 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (1) , 41
Beyond Strict Physics: Using Poiseuille’s Law as a Practical Framework to Optimize and Personalize Cementoplasty
Background/Objectives: Poiseuille’s law describes the influence of radius, length, viscosity, and pressure on the flow of Newtonian fluids. Although bone cement is a non-Newtonian, shear-thinning, and polymerizing material that does not comply with this law in any predictive or quantitative sense, its qualitative principles may offer a didactic framework for understanding factors that affect injectability during cementoplasty. The objective of this Technical Note is to provide an educational and conceptual interpretation of Poiseuille’s law as it relates to trocar selection, cement behavior, and procedural planning. Methods: This work presents theoretical calculations based on the r4/L component of Poiseuille’s equation, using manufacturer-specified internal radii for commonly used trocars. Relative flow rates were computed as r4/L ratios normalized to a 13-gauge, 15 cm trocar. Conceptual viscosity profiles illustrate qualitative differences among cements over time. A representative, fully anonymized clinical example is provided to illustrate the integration of these conceptual principles into practice. No experimental measurements were performed. Results: Theoretical calculations show that trocar radius has the strongest influence on theoretical flow, with an exponential effect (r4), whereas increasing trocar length proportionally reduces flow. Conceptual viscosity curves demonstrate the rapid rise in viscosity during polymerization and highlight the importance of timing and cement selection. The clinical example illustrates how trocar choice, access planning, and cement viscosity are adapted to lesion morphology and cortical integrity. Conclusions: Poiseuille’s law cannot model or predict bone cement behavior and has no procedural or clinical validity in cementoplasty. Its use in this Technical Note is strictly educational, providing a qualitative framework to illustrate general relationships between equipment characteristics, viscosity evolution, and resistance during injection, without offering clinical guidance or implying any impact on procedural planning, safety, or outcomes.
- 8 January 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (1) , 41
Open AccessBeyond Strict Physics: Using Poiseuille’s Law as a Practical Framework to Optimize and Personalize Cementoplasty
Background/Objectives: Poiseuille’s law describes the influence of radius, length, viscosity, and pressure on the flow of Newtonian fluids. Although bone cement is a non-Newtonian, shear-thinning, and polymerizing material that does not comply with this law in any predictive or quantitative sense, its qualitative principles may offer a didactic framework for understanding factors that affect injectability during cementoplasty. The objective of this Technical Note is to provide an educational and conceptual interpretation of Poiseuille’s law as it relates to trocar selection, cement behavior, and procedural planning. Methods: This work presents theoretical calculations based on the r4/L component of Poiseuille’s equation, using manufacturer-specified internal radii for commonly used trocars. Relative flow rates were computed as r4/L ratios normalized to a 13-gauge, 15 cm trocar. Conceptual viscosity profiles illustrate qualitative differences among cements over time. A representative, fully anonymized clinical example is provided to illustrate the integration of these conceptual principles into practice. No experimental measurements were performed. Results: Theoretical calculations show that trocar radius has the strongest influence on theoretical flow, with an exponential effect (r4), whereas increasing trocar length proportionally reduces flow. Conceptual viscosity curves demonstrate the rapid rise in viscosity during polymerization and highlight the importance of timing and cement selection. The clinical example illustrates how trocar choice, access planning, and cement viscosity are adapted to lesion morphology and cortical integrity. Conclusions: Poiseuille’s law cannot model or predict bone cement behavior and has no procedural or clinical validity in cementoplasty. Its use in this Technical Note is strictly educational, providing a qualitative framework to illustrate general relationships between equipment characteristics, viscosity evolution, and resistance during injection, without offering clinical guidance or implying any impact on procedural planning, safety, or outcomes.
- Open Access
- 29 July 2025
- Published by Georg Thieme Verlag KG in Journal of Clinical Interventional Radiology ISVIR
- Vol. 10 (02) , 144-147
Direct-Puncture-Guided Sharp Recanalization Technique in a Case of Long-Segment Superior Mesenteric Vein Occlusion
We describe the case of a moderately long chronic superior mesenteric vein (SMV) occlusion following Whipple procedure. Anticoagulation therapy and traditional recanalization techniques through retrograde approach, collateral inferior mesenteric venous vasculature, and recanalization upstream of the SMV occlusion via direct transabdominal puncture failed. Sharp recanalization downstream of the occlusion via retrograde approach, using the stiff end of a glidewire sharpened with a blade, with guidance from the tip of a catheter placed upstream of the occlusion as a target was successful. Our rendezvous technique, combined with use of orthogonal views, allowed for increased precision and decreased risk of catastrophic extravasation.
- 29 July 2025
- Published by Georg Thieme Verlag KG in Journal of Clinical Interventional Radiology ISVIR
- Vol. 10 (02) , 144-147
Open AccessDirect-Puncture-Guided Sharp Recanalization Technique in a Case of Long-Segment Superior Mesenteric Vein Occlusion
We describe the case of a moderately long chronic superior mesenteric vein (SMV) occlusion following Whipple procedure. Anticoagulation therapy and traditional recanalization techniques through retrograde approach, collateral inferior mesenteric venous vasculature, and recanalization upstream of the SMV occlusion via direct transabdominal puncture failed. Sharp recanalization downstream of the occlusion via retrograde approach, using the stiff end of a glidewire sharpened with a blade, with guidance from the tip of a catheter placed upstream of the occlusion as a target was successful. Our rendezvous technique, combined with use of orthogonal views, allowed for increased precision and decreased risk of catastrophic extravasation.
- Open Access
- 9 May 2024
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 96 (2) , 12306
Prostatic artery embolization for intractable hematuria in patients with unregulated coagulation parameters: three case reports
Introduction: Benign prostatic hyperplasia is a prevalent disease that could be responsible of severe intractable hematuria requiring invasive surgical management. Case presentation: We report three high-risk cases presented with intractable hematuria of prostatic origin with high medical co-morbidities treated safely and effectively by prostatic artery embolization with favorable outcomes. Conclusions: In non-surgical, anticoagulated patients, prostatic artery embolization represents a safe and effective intervention for the treatment of intractable hematuria related to benign prostatic hyperplasia.
- 9 May 2024
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 96 (2) , 12306
Open AccessProstatic artery embolization for intractable hematuria in patients with unregulated coagulation parameters: three case reports
Introduction: Benign prostatic hyperplasia is a prevalent disease that could be responsible of severe intractable hematuria requiring invasive surgical management. Case presentation: We report three high-risk cases presented with intractable hematuria of prostatic origin with high medical co-morbidities treated safely and effectively by prostatic artery embolization with favorable outcomes. Conclusions: In non-surgical, anticoagulated patients, prostatic artery embolization represents a safe and effective intervention for the treatment of intractable hematuria related to benign prostatic hyperplasia.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
Supplementary Table 1 shows the clinical characteristics of the patients from whom patient-derived xenografts were generated and evaluated in the preclinical trial
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
Supplementary Table 1 shows the clinical characteristics of the patients from whom patient-derived xenografts were generated and evaluated in the preclinical trial
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
Supplementary Figure 2 shows the results of a pilot monotherapy trial to evaluate regimen-related toxicity
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from A Preclinical Trial and Molecularly Annotated Patient Cohort Identify Predictive Biomarkers in Homologous Recombination–deficient Pancreatic Cancer
Supplementary Figure 2 shows the results of a pilot monotherapy trial to evaluate regimen-related toxicity